Login

Journal Image
Combinatorial Chemistry & High Throughput Screening
ISSN (Print): 1386-2073
ISSN (Online): 1875-5402
VOLUME: 17
ISSUE: 3
DOI: 10.2174/1386207317666140109122033









From HTS to Phase I: The Institute for Therapeutics Discovery and Development at the University of Minnesota

img
Author(s): Peter I. Dosa, Gunda I. Georg, Vadim J. Gurvich, Jon E. Hawkinson, Michael A. Walters and Henry L. Wong
Pages 231-240 (10)
Abstract:
The high-throughput screening core at the University of Minnesota is part of the Institute for Therapeutics Discovery and Development (ITDD), a comprehensive drug discovery and development center. The Institute provides scientific services to both academic and business communities and supports translational medicine via collaborations and contractual work. The ITDD is well-known for its broad range of screening capabilities and offers extensive medicinal chemistry expertise along with GMP scale-up and pre-clinical pharmacology support.
Keywords:
Drug development, drug discovery, good manufacturing practices (GMP), high throughput screening (HTS), medicinal chemistry, pharmacology, scale-up, translational science.
Affiliation:
Institute for Therapeutics Discovery and Development, 717 Delaware St. SE, Minneapolis, MN 55414, USA.